Last updated: October 02, 2026

Application No. 18/255,420

PRODUCTION OF FUNGAL BIOMASS

Final Rejection

Filed

Jun 01, 2023

Priority

Dec 24, 2020 — EU 20217228.4 +1 more

Examiner

ARIANI, KADE

Art Unit

1651

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Mushlabs GmbH

OA Round

2 (Final)

Interview Optional

— +32.4% interview lift. Examiner has a relatively high allowance rate (75%); +32.4% interview lift. A written response may suffice.

Based on 840 resolved cases, 2023–2026

Examiner Intelligence

ARIANI, KADE View full profile →

Grants 75% — above average

Career Allowance Rate

629 granted / 840 resolved

+14.9% vs TC avg

Strong +32% interview lift

Without

With

+32.4%

Interview Lift

resolved cases with interview

Typical timeline

2y 10m

Avg Prosecution

36 currently pending

Career history

864

Total Applications

across all art units

Statute-Specific Performance

§101

4.3%

-35.7% vs TC avg

§103

34.8%

-5.2% vs TC avg

§102

15.2%

-24.8% vs TC avg

§112

32.2%

-7.8% vs TC avg

Black line = Tech Center average estimate • Based on career data from 840 resolved cases

Prosecution Timeline

Jun 01, 2023

Application Filed

Feb 11, 2026

Non-Final Rejection mailed

Jul 01, 2026

Response Filed

Jul 14, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/550,815

Patent 12742147

METHODS AND SYSTEMS FOR GROWING MICROBIAL MASS

3y 0m to grant Granted Sep 22, 2026

18/628,860

Patent 12735735

DIGITAL MICROBIOLOGY

2y 5m to grant Granted Sep 15, 2026

18/429,790

Patent 12697358

LACTIC ACID BACTERIAL COMPOSITION FOR MODULATING IMMUNE CELL DIFFERENTIATION AND/OR REDUCING PRO-INFLAMMATORY CYTOKINE SECRETION AND USE THEREOF

2y 6m to grant Granted Aug 04, 2026

18/770,789

Patent 12697359

COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH COMPRISING POSTBIOTIC COMPONENTS FROM HEAT-TREAT LIMOSILACTOBACILLUS FERMENTUM LM1020

2y 0m to grant Granted Aug 04, 2026

19/267,709

Patent 12678467

MIXED BIFIDOBACTERIUM STRAIN WITH EXCELLENT PRODUCTIVITY AND ANTI-INFLAMMATORY ACTIVITY, AND USES THEREOF

1y 0m to grant Granted Jul 14, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

75%

Grant Probability

99%

With Interview (+32.4%)

2y 10m (~0m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 840 resolved cases by this examiner. Grant probability derived from career allowance rate.